Nitrogen monoxide synthase inhibitor, its preparation method and application

A compound, methoxy technology, applied in the field of nitric oxide synthase inhibitors, can solve problems affecting application value

Inactive Publication Date: 2003-07-09
CHINA PHARM UNIV
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In 1997, Shearer BG et al. (Shearer BG, et al. J Med Chem.1997, 40 (12): 1901-1905) reported that S-ethyl-N-substituted phenylisothiourea has a strong NOS inhibitory effect, And it is selective to nNOS, but they are eliminated rapidly in the body, which affects its application value

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Nitrogen monoxide synthase inhibitor, its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0046] The preparation of example 1S-methyl-N-[4-(benzimidazole-2-mercapto) phenyl] isothiourea hydroiodide (I-1) Imidazole (III-1):

[0047] Add 9.5g (63.3mmol) of 2-mercaptobenzimidazole, 60ml of anhydrous acetonitrile, 2.53g (63.3mmol) of powdered sodium hydroxide, 9.98g (63.3mmol) of p-nitrochlorobenzene and 1.0g of PEG-400 into the pressure-resistant In the bottle, place it in an oil bath at 120°C under electromagnetic stirring for 28 hours, cool, filter with suction, wash twice with cold acetonitrile, and then wash with water to pH 7 to obtain 15.1 g (87.9%) of yellow solid (III-1), mp 185~ 186°C. 1 HNMR (90MHz, CDCl 3 +DMSO-d 6 ), δ(ppm): 7.17~7.32(2H, m, ArH), 7.47~7.62(4H, m, ArH), 8.04~8.20(2H, m, ArH)2-(4-aminophenylsulfanyl)benzene And imidazole (IV-1):

[0048] Add 10 g (179 mmol) of reduced iron powder and 200 ml of 95% ethanol into a three-neck flask, add 8.4 ml of 10% HCl dropwise under mechanical stirring, and after 10 min, add 1...

example 2

[0052] The preparation of example 2S-ethyl-N-[4-(benzimidazole-2-mercapto) phenyl] isothiourea hydroiodide (I-2)

[0053] Using compound (VI-1) and iodoethane (molar ratio 1:3) as raw materials, a method similar to compound (I-1) was used to obtain pale yellow crystals (I-2, 54.8%), mp 148-150°C. IR (cm -1 ): 3443, 3407(NH), 3135~2835( + NH 3 ), 3082 (ArH), 2977, 2930 (CH), 1628, 1546, 1524 (C=C, C=N), 1426, 1403 (imidazole), 1269 (-SCH 2 -), 749 (ArH, ortho-disubstituted) 1 HNMR (90MHz, DMSO-d 6 +CDCl 3 ), δ (ppm): 1.38 (3H, t, J=7.33Hz, -S-CH 2 -CH 3 ), 3.30 (2H, q, J=7.08Hz, -S-CH 2 -), 7.16~7.58 (8H, m, ArH), 7.58~9.80 (4H, br, + NH 3 +NH) MS (SCI 70eV, m / z): 329 (M+1), 312 (M-16), 284, 254, 242 (base peak) Anal (C 16 h 16 N 4 S 2 .HI; C%, H%, N%): Req 42.11, 3.75, 12.28 Found 41.89, 3.84, 12.06

example 3

[0054] The preparation of example 3S-n-butyl-N-[4-(benzimidazole-2-mercapto) phenyl] isothiourea hydroiodide (I-3)

[0055] Using compound (VI-1) and iodo-n-butane (molar ratio 1:3) as raw materials, a method similar to compound (I-1) was used to obtain light yellow crystals (I-3, 62%), mp 176-177 ℃IR(cm -1 ): 3149~2734 ( + NH 3 ), 3077 (ArH), 2958, 2928 (CH), 1627, 1587, 1544, 1516 (C=C, C=N), 1422, 1407 (imidazole), 1269 (-SCH 2 -), 737 (ArH, ortho-disubstituted) 1 HNMR (90MHz, DMSO-d 6 +CDCl 3 ), δ (ppm): 0.95 (3H, t, J=6.48Hz, -S-(CH 2 ) 3 -CH 3 ), 1.33~1.77 (4H, m, -S-CH 2 -CH 2 CH 2 -CH 3 ), 3.26 (2H, t, J=7.02Hz, -S-CH2-), 7.14~7.67 (8H, m, ArH), 7.7~10.0 (4H, br, + NH 3 +NH) MS (SCI 70eV m / z): 357 (M+1), 284, 242, 184, 57 (base peak) Anal (C 18 h 20 N 4 S 2 HI; C%, H%, N%): Req 44.63, 4.37, 11.57 Found 44.36, 4.55, 11.29

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to a compound-laughing gas synthase inhibitor. Said invention also provides its general formula and its preparation method, and also discloses the medicine containing said compound and its application for curing the diseases of septic shock, enteritis, rheumatoid arthritis, diabetes mellitus, cerebral ischemic injury and presenile dementia, etc.

Description

technical field [0001] The present invention relates to novel isothiourea compounds, their preparation methods, pharmaceutical compositions containing these compounds and their medical use, especially as nitric oxide synthase inhibitors. Background technique [0002] Septic shock is currently a refractory disease, there is no effective drug in clinical practice, and the mortality rate is extremely high. Certain diseases such as arthritis still do not have good treatment medicines at present. The excess NO catalyzed by iNOS is an important cause of septic shock and inflammation. Therefore, the development of iNOS inhibitors has potential therapeutic value for these diseases. [0003] In recent years, a lot of progress has been made in the study of NOS inhibitors, among which, compounds containing isothiourea structures have better NOS inhibitory activity (Southan GJ, Szabo C. Biochem Pharmacol. 1996, 51: 383-394). In 1997, Shearer BG et al. (Shearer BG, et al. J Med Chem.19...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/4188A61K31/428A61P1/00A61P3/10A61P9/10A61P25/28A61P29/00C07D235/28C07D277/70
Inventor 徐云根华维一朱东亚罗穗
Owner CHINA PHARM UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap